TR200102393T2 - Fukozil transferaz geni. - Google Patents
Fukozil transferaz geni.Info
- Publication number
- TR200102393T2 TR200102393T2 TR2001/02393T TR200102393T TR200102393T2 TR 200102393 T2 TR200102393 T2 TR 200102393T2 TR 2001/02393 T TR2001/02393 T TR 2001/02393T TR 200102393 T TR200102393 T TR 200102393T TR 200102393 T2 TR200102393 T2 TR 200102393T2
- Authority
- TR
- Turkey
- Prior art keywords
- sequencing
- fucosyl transferase
- homologous
- base pair
- transferase gene
- Prior art date
Links
- 108010019236 Fucosyltransferases Proteins 0.000 title abstract 2
- 238000012163 sequencing technique Methods 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 238000001712 DNA sequencing Methods 0.000 abstract 1
- 102000006471 Fucosyltransferases Human genes 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 108010064851 Plant Proteins Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 235000021118 plant-derived protein Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0027099A AT408446B (de) | 1999-02-18 | 1999-02-18 | Fucosyltransferase-gen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200102393T2 true TR200102393T2 (tr) | 2002-04-22 |
Family
ID=3486087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/02393T TR200102393T2 (tr) | 1999-02-18 | 2000-02-17 | Fukozil transferaz geni. |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US20080234471A1 (https=) |
| EP (3) | EP1642979A1 (https=) |
| JP (2) | JP5514386B2 (https=) |
| KR (1) | KR20010108234A (https=) |
| CN (1) | CN1360633A (https=) |
| AT (2) | AT408446B (https=) |
| AU (1) | AU771995B2 (https=) |
| BG (1) | BG65140B1 (https=) |
| BR (1) | BR0010114A (https=) |
| CA (1) | CA2362964C (https=) |
| CZ (2) | CZ308081B6 (https=) |
| DE (1) | DE50011116D1 (https=) |
| DK (2) | DK2062977T3 (https=) |
| EE (1) | EE200100432A (https=) |
| ES (2) | ES2444126T3 (https=) |
| HR (1) | HRP20010681A2 (https=) |
| HU (1) | HU230075B1 (https=) |
| IL (2) | IL144777A0 (https=) |
| IS (1) | IS6041A (https=) |
| MX (1) | MXPA01008372A (https=) |
| NO (1) | NO20013993L (https=) |
| NZ (1) | NZ513685A (https=) |
| PL (2) | PL205710B1 (https=) |
| PT (1) | PT2062977E (https=) |
| SK (1) | SK286416B6 (https=) |
| TR (1) | TR200102393T2 (https=) |
| WO (1) | WO2000049153A1 (https=) |
| YU (1) | YU58901A (https=) |
| ZA (1) | ZA200106735B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1137789T3 (da) | 1998-12-09 | 2010-11-08 | Phyton Holdings Llc | Fremgangsmåde til fremstilling af et glycoprotein med glycosylering af human type |
| AT408446B (de) * | 1999-02-18 | 2001-11-26 | Altmann Friedrich Dr | Fucosyltransferase-gen |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| DE60044858D1 (de) | 1999-10-26 | 2010-09-30 | Stichting Dienst Landbouwkundi | Säugetierartige Glykosylierung in Pflanzen |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| DK1356068T3 (en) | 2001-01-19 | 2015-02-16 | Phyton Holdings Llc | PROCESS FOR THE PRODUCTION OF secretory glycoprotein with HUMAN TYPE SUGAR CHAIN FOR USING A PLANT CELL |
| CN101613705A (zh) | 2002-03-19 | 2009-12-30 | 国际植物研究所 | 在植物中优化聚糖生成 |
| CN1665934B (zh) | 2002-03-19 | 2010-05-26 | 国际植物研究所 | GNTIII(UDP-N乙酰葡萄糖胺:β-D-甘露糖苷β(1,4)-N-乙酰葡萄糖胺基-转移酶III)在植物中的表达 |
| ATE503829T1 (de) | 2002-04-09 | 2011-04-15 | Kyowa Hakko Kirin Co Ltd | Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins |
| CL2003002461A1 (es) | 2002-11-27 | 2005-01-07 | Dow Chemical Company Agroscien | Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas. |
| EP1510584B1 (en) | 2003-08-11 | 2009-03-18 | Greenovation Biotech GmbH | Expression promoting sequences from mosses and their uses |
| FI20055398A0 (fi) | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
| JP2009526520A (ja) | 2006-01-17 | 2009-07-23 | バイオレックス セラピュティックス インク | 植物中でのｎ−グリカンのヒト化及び最適化のための組成物及び方法 |
| US20090060921A1 (en) * | 2006-01-17 | 2009-03-05 | Biolex Therapeutics, Inc. | Glycan-optimized anti-cd20 antibodies |
| CN102094019B (zh) * | 2007-01-15 | 2012-11-28 | 燕秋 | 用于抑制LeY糖抗原合成的岩藻糖基转移酶Ⅳ的RNA干涉序列及重组干涉质粒 |
| CN102094020B (zh) * | 2007-01-15 | 2012-11-28 | 燕秋 | 用于抑制LeY糖抗原合成的岩藻糖基转移酶I的RNA干涉序列及重组干涉质粒 |
| WO2008125972A2 (en) | 2007-04-17 | 2008-10-23 | Plant Research International B.V. | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
| WO2009033011A1 (en) * | 2007-09-07 | 2009-03-12 | Children's Hospital Medical Center | Use of secretor, lewis and sialyl antigen levels as predictors for disease |
| WO2009056155A1 (en) * | 2007-10-31 | 2009-05-07 | Bayer Bioscience N.V. | Method to produce modified plants with altered n-glycosylation pattern |
| EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
| EP2944690B1 (en) | 2010-10-11 | 2017-12-20 | Jennewein Biotechnologie GmbH | Novel fucosyltransferases and their applications |
| KR101293658B1 (ko) * | 2010-12-30 | 2013-08-07 | 대한민국 | 알파-1,3-푸코실트랜스퍼라아제 및/또는 베타-1,2-자일로실트렌스퍼라아제 유전자를 포함하는 벼 형질전환용 벡터 및 형질전환된 벼 |
| EP2479263B1 (en) * | 2011-01-20 | 2013-11-27 | Jennewein Biotechnologie GmbH | Novel Fucosyltransferases and their applications |
| EP2789686A1 (en) | 2013-04-11 | 2014-10-15 | Greenovation Biotech GmbH | Expression of phosphorylated glycoproteins in plants |
| EP3050973A1 (en) * | 2015-01-30 | 2016-08-03 | Jennewein Biotechnologie GmbH | Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars |
| CN110317799B (zh) * | 2019-07-18 | 2026-04-03 | 江南大学 | 一种人源岩藻糖转移酶8的原核表达方法及其产品 |
| EP3871687A1 (en) | 2020-02-27 | 2021-09-01 | eleva GmbH | Enzyme replacement therapy for treating pompe disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5272066A (en) | 1986-03-07 | 1993-12-21 | Massachusetts Institute Of Technology | Synthetic method for enhancing glycoprotein stability |
| JP3756946B2 (ja) | 1993-03-29 | 2006-03-22 | 協和醗酵工業株式会社 | α１，３−フコシルトランスフェラーゼ |
| US6509149B2 (en) * | 1995-06-06 | 2003-01-21 | Hybridon, Inc. | HPV-specific oligonucleotides |
| US5770420A (en) * | 1995-09-08 | 1998-06-23 | The Regents Of The University Of Michigan | Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
| AT408446B (de) * | 1999-02-18 | 2001-11-26 | Altmann Friedrich Dr | Fucosyltransferase-gen |
-
1999
- 1999-02-18 AT AT0027099A patent/AT408446B/de not_active IP Right Cessation
-
2000
- 2000-02-17 PL PL385768A patent/PL205710B1/pl unknown
- 2000-02-17 CN CN00805192A patent/CN1360633A/zh active Pending
- 2000-02-17 EP EP05108012A patent/EP1642979A1/de not_active Withdrawn
- 2000-02-17 KR KR1020017010518A patent/KR20010108234A/ko not_active Ceased
- 2000-02-17 DK DK09154489.0T patent/DK2062977T3/da active
- 2000-02-17 DE DE50011116T patent/DE50011116D1/de not_active Expired - Lifetime
- 2000-02-17 WO PCT/AT2000/000040 patent/WO2000049153A1/de not_active Ceased
- 2000-02-17 PL PL363438A patent/PL205785B1/pl unknown
- 2000-02-17 CA CA2362964A patent/CA2362964C/en not_active Expired - Lifetime
- 2000-02-17 PT PT91544890T patent/PT2062977E/pt unknown
- 2000-02-17 EP EP00904677A patent/EP1151109B1/de not_active Expired - Lifetime
- 2000-02-17 CZ CZ2008-404A patent/CZ308081B6/cs not_active IP Right Cessation
- 2000-02-17 EE EEP200100432A patent/EE200100432A/xx unknown
- 2000-02-17 DK DK00904677T patent/DK1151109T3/da active
- 2000-02-17 SK SK1118-2001A patent/SK286416B6/sk not_active IP Right Cessation
- 2000-02-17 BR BR0010114-1A patent/BR0010114A/pt not_active Application Discontinuation
- 2000-02-17 AT AT00904677T patent/ATE304053T1/de active
- 2000-02-17 HR HR20010681A patent/HRP20010681A2/hr not_active Application Discontinuation
- 2000-02-17 EP EP09154489.0A patent/EP2062977B1/de not_active Expired - Lifetime
- 2000-02-17 AU AU26460/00A patent/AU771995B2/en not_active Expired
- 2000-02-17 JP JP2000599878A patent/JP5514386B2/ja not_active Expired - Lifetime
- 2000-02-17 YU YU58901A patent/YU58901A/sh unknown
- 2000-02-17 ES ES09154489.0T patent/ES2444126T3/es not_active Expired - Lifetime
- 2000-02-17 ES ES00904677T patent/ES2246222T3/es not_active Expired - Lifetime
- 2000-02-17 NZ NZ513685A patent/NZ513685A/en unknown
- 2000-02-17 CZ CZ20012943A patent/CZ299622B6/cs not_active IP Right Cessation
- 2000-02-17 HU HU0200394A patent/HU230075B1/hu unknown
- 2000-02-17 IL IL14477700A patent/IL144777A0/xx active IP Right Grant
- 2000-02-17 TR TR2001/02393T patent/TR200102393T2/xx unknown
- 2000-02-17 MX MXPA01008372A patent/MXPA01008372A/es active IP Right Grant
-
2001
- 2001-08-07 IL IL144777A patent/IL144777A/en not_active IP Right Cessation
- 2001-08-08 IS IS6041A patent/IS6041A/is unknown
- 2001-08-15 ZA ZA200106735A patent/ZA200106735B/en unknown
- 2001-08-16 NO NO20013993A patent/NO20013993L/no unknown
- 2001-09-13 BG BG105899A patent/BG65140B1/bg unknown
-
2007
- 2007-06-06 US US11/808,096 patent/US20080234471A1/en not_active Abandoned
- 2007-06-06 US US11/808,097 patent/US8198078B2/en not_active Expired - Fee Related
-
2011
- 2011-01-04 JP JP2011000049A patent/JP2011120592A/ja active Pending
-
2012
- 2012-05-15 US US13/471,759 patent/US8895806B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200102393T2 (tr) | Fukozil transferaz geni. | |
| Maruyama et al. | Evolution of the transposable element mariner in Drosophila species | |
| DK0920498T3 (da) | Hamster EF-1alfa transskriptionelt, regulatorisk DNA | |
| TR200001709T2 (tr) | Yeni neisseria meningitids yüzey proteini | |
| EP1647281A3 (fr) | Formule de vaccin polynucléotidique contre les pathologies du cheval | |
| CA2199821A1 (en) | Cloning and regulation of an endothelial cell protein c/activated protein c receptor | |
| DE69932599D1 (de) | Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten | |
| ATE371022T1 (de) | Fy7 polymerase | |
| PT973794E (pt) | Receptores de netrina | |
| ATE473283T1 (de) | Dna-expressionsvektoren | |
| TR200200693T2 (tr) | Gen ifadesinin kontrolü için bitkisel düzenleyici sekanslar | |
| DK1390543T3 (da) | Nye polynukleotider og polypeptider af IFNalfa-17-genet | |
| WO1998011234A3 (en) | Human protein kinases | |
| DE60117053D1 (de) | Herstellung rekombinanter künstlicher hefe-chromosome, welche das genom des humanen cytomegalovirus enthalten | |
| DE69836136D1 (de) | Rekombinantes konstrukt für eine erhöhte expression von genen in pflanzen. | |
| MD20000034A (ro) | Proteinele virusului răsucirii frunzelor de viţă de vie (tipul 2) şi utilizarea lor | |
| EP0815240A4 (en) | NEW HUMAN PROTEINS, LIKE CYCLINE-DEPENDENT KINASES, AND METHODS TO USE THEM | |
| DK57487D0 (da) | Humant lymphotoxinpolypeptidderivat og fremgangsmaade til fremstilling deraf, dna-fragment, som koder for derivatet, rekombinante plasmider, som har inkorporeret fragmentet, og biologisk rene kulturer af mikroorganismer indeholdende saadanne plasmider | |
| HUP9900789A2 (hu) | Lefelé irányuló szabályozásra rezisztens C3 konvertáz | |
| HK1047113A1 (zh) | 一种编码a2b-肾上腺素受体蛋白变体的dna分子及其应用 | |
| DE60332213D1 (de) | Identifikation von 3-ketosteroid 9-alfa-hydroxylase genen und blockierte mikroorganismen in 3-ketosteroid 9-alfa-hydroxylase aktivität | |
| BR9801703A (pt) | Purificação de complexos de transcrição de ordem superior a partir de animais não-humanos transgênicos. | |
| DE60030734D1 (de) | Mites-ähnliches element und an trankriptionsaktivierung beteiligtes element | |
| Müller et al. | The two main rDNA size classes of Ascaris lumbricoides: comparison of transcription termination and spacer organization | |
| WO2003050311A3 (en) | Methods and compositions for diagnosing and treating hypotrichosis simplex |